Company Filing History:
Years Active: 2014
Title: The Innovations of Pascal Cardinael
Introduction
Pascal Cardinael is a notable inventor based in Isneauville, France. He has made significant contributions to the field of chemistry, particularly in the area of enantiomeric separation processes. His work is aimed at addressing critical health issues, including those related to insulin-resistance syndrome.
Latest Patents
Cardinael holds a patent for a process titled "Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization." This innovative process focuses on the enantiomeric separation of racemic 3,6-dihydro-1,3,5-triazine derivatives. The method utilizes preferential crystallization to enhance the treatment of disorders associated with insulin-resistance syndrome.
Career Highlights
Throughout his career, Pascal Cardinael has been associated with Poxel, a company dedicated to developing innovative treatments for metabolic diseases. His expertise in chemistry and patentable inventions has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Cardinael has collaborated with notable colleagues, including Matthias Helmreich and Claus-Peter Niesert. These partnerships have contributed to the advancement of research and development in their respective fields.
Conclusion
Pascal Cardinael's work exemplifies the impact of innovative thinking in addressing complex health challenges. His contributions to the field of chemistry and his patent for enantiomeric separation processes highlight the importance of research in developing effective treatments.